High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common inherited human enzyme defect. This deficiency provides some protection from clinical malaria, but it can also cause haemolysis after administration of drugs with oxidant properties. Methods The safety of chlorproguani...
Main Authors: | Fanello, C, Karema, C, Avellino, P, Bancone, G, Uwimana, A, Lee, S, D'Alessandro, U, Modiano, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2008
|
Similar Items
-
A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria.
by: Fanello, C, et al.
Published: (2008) -
Chlorproguanil-dapsone for malaria in Africa.
by: Looareesuwan, S, et al.
Published: (2004) -
Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.
by: Amukoye, E, et al.
Published: (1997) -
Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
by: Winstanley, P, et al.
Published: (1997) -
A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children.
by: Greenwood, B, et al.
Published: (1989)